Project
Illumina Body Map 2
Navigation
Downloads
Results for EZH2
Z-value: 2.38
Motif logo
Transcription factors associated with EZH2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
EZH2
|
ENSG00000106462.6 | enhancer of zeste 2 polycomb repressive complex 2 subunit |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| EZH2 | hg19_v2_chr7_-_148581251_148581347 | -0.41 | 2.0e-02 | Click! |
Activity profile of EZH2 motif
Sorted Z-values of EZH2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr3_-_116164306 | 12.59 |
ENST00000490035.2
|
LSAMP
|
limbic system-associated membrane protein |
| chr15_+_43885252 | 11.31 |
ENST00000453782.1
ENST00000300283.6 ENST00000437924.1 ENST00000450086.2 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
| chr3_+_115342159 | 10.20 |
ENST00000305124.6
|
GAP43
|
growth associated protein 43 |
| chr11_+_27062272 | 9.61 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr5_+_175298487 | 9.19 |
ENST00000393745.3
|
CPLX2
|
complexin 2 |
| chr4_+_24797085 | 8.85 |
ENST00000382120.3
|
SOD3
|
superoxide dismutase 3, extracellular |
| chr3_+_115342349 | 8.83 |
ENST00000393780.3
|
GAP43
|
growth associated protein 43 |
| chr11_-_111781610 | 8.66 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
| chr15_+_43985084 | 8.57 |
ENST00000434505.1
ENST00000411750.1 |
CKMT1A
|
creatine kinase, mitochondrial 1A |
| chr5_+_92919043 | 8.39 |
ENST00000327111.3
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1 |
| chr11_-_111781554 | 7.65 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
| chr13_-_108518986 | 7.28 |
ENST00000375915.2
|
FAM155A
|
family with sequence similarity 155, member A |
| chr3_-_195538728 | 7.03 |
ENST00000349607.4
ENST00000346145.4 |
MUC4
|
mucin 4, cell surface associated |
| chr15_+_43886057 | 6.65 |
ENST00000441322.1
ENST00000413657.2 ENST00000453733.1 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
| chr19_-_35626104 | 6.62 |
ENST00000310123.3
ENST00000392225.3 |
LGI4
|
leucine-rich repeat LGI family, member 4 |
| chr11_-_111781454 | 6.55 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
| chr12_+_7167980 | 6.30 |
ENST00000360817.5
ENST00000402681.3 |
C1S
|
complement component 1, s subcomponent |
| chr18_-_40695604 | 5.49 |
ENST00000590910.1
ENST00000326695.5 ENST00000589109.1 ENST00000282028.4 |
RIT2
|
Ras-like without CAAX 2 |
| chr5_+_175298573 | 5.44 |
ENST00000512824.1
|
CPLX2
|
complexin 2 |
| chr10_+_18629628 | 5.44 |
ENST00000377329.4
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
| chr3_+_111717511 | 5.37 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
| chr3_-_195310802 | 5.29 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
| chr20_-_42816206 | 5.15 |
ENST00000372980.3
|
JPH2
|
junctophilin 2 |
| chr9_+_133971909 | 4.93 |
ENST00000247291.3
ENST00000372302.1 ENST00000372300.1 ENST00000372298.1 |
AIF1L
|
allograft inflammatory factor 1-like |
| chr14_+_79745746 | 4.93 |
ENST00000281127.7
|
NRXN3
|
neurexin 3 |
| chrX_+_28605516 | 4.89 |
ENST00000378993.1
|
IL1RAPL1
|
interleukin 1 receptor accessory protein-like 1 |
| chr2_+_210288760 | 4.70 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
| chr15_+_43985725 | 4.70 |
ENST00000413453.2
|
CKMT1A
|
creatine kinase, mitochondrial 1A |
| chr6_+_19837592 | 4.67 |
ENST00000378700.3
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
| chr11_-_66496655 | 4.67 |
ENST00000527010.1
|
SPTBN2
|
spectrin, beta, non-erythrocytic 2 |
| chr12_-_6484376 | 4.67 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr2_+_220325441 | 4.65 |
ENST00000396688.1
|
SPEG
|
SPEG complex locus |
| chr5_-_142077569 | 4.60 |
ENST00000407758.1
ENST00000441680.2 ENST00000419524.2 |
FGF1
|
fibroblast growth factor 1 (acidic) |
| chr11_-_62689046 | 4.60 |
ENST00000306960.3
ENST00000543973.1 |
CHRM1
|
cholinergic receptor, muscarinic 1 |
| chr12_-_6483969 | 4.56 |
ENST00000396966.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr6_+_123100620 | 4.53 |
ENST00000368444.3
|
FABP7
|
fatty acid binding protein 7, brain |
| chr9_+_133971863 | 4.50 |
ENST00000372309.3
|
AIF1L
|
allograft inflammatory factor 1-like |
| chr7_-_22233442 | 4.49 |
ENST00000401957.2
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
| chr15_+_63335899 | 4.36 |
ENST00000561266.1
|
TPM1
|
tropomyosin 1 (alpha) |
| chr10_-_97175444 | 4.33 |
ENST00000486141.2
|
SORBS1
|
sorbin and SH3 domain containing 1 |
| chr15_+_43885799 | 4.32 |
ENST00000449946.1
ENST00000417289.1 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
| chr18_-_24443151 | 4.32 |
ENST00000440832.3
|
AQP4
|
aquaporin 4 |
| chr11_-_133402410 | 4.31 |
ENST00000524381.1
|
OPCML
|
opioid binding protein/cell adhesion molecule-like |
| chr1_+_160097462 | 4.28 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
| chr13_-_103053946 | 4.28 |
ENST00000376131.4
|
FGF14
|
fibroblast growth factor 14 |
| chr8_-_13372253 | 4.27 |
ENST00000316609.5
|
DLC1
|
deleted in liver cancer 1 |
| chr16_+_80574854 | 4.21 |
ENST00000305904.6
ENST00000568035.1 |
DYNLRB2
|
dynein, light chain, roadblock-type 2 |
| chr6_+_76599809 | 4.20 |
ENST00000430435.1
|
MYO6
|
myosin VI |
| chrX_+_122318224 | 4.13 |
ENST00000542149.1
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3 |
| chr3_-_187009646 | 4.12 |
ENST00000296280.6
ENST00000392470.2 ENST00000169293.6 ENST00000439271.1 ENST00000392472.2 ENST00000392475.2 |
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
| chr3_-_195538760 | 4.11 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
| chr16_-_29910853 | 4.09 |
ENST00000308713.5
|
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
| chr1_+_209859510 | 4.07 |
ENST00000367028.2
ENST00000261465.1 |
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
| chrX_+_103031421 | 4.04 |
ENST00000433491.1
ENST00000418604.1 ENST00000443502.1 |
PLP1
|
proteolipid protein 1 |
| chr8_-_27115903 | 4.04 |
ENST00000350889.4
ENST00000519997.1 ENST00000519614.1 ENST00000522908.1 ENST00000265770.7 |
STMN4
|
stathmin-like 4 |
| chr13_+_93879085 | 4.03 |
ENST00000377047.4
|
GPC6
|
glypican 6 |
| chr1_-_145076186 | 4.03 |
ENST00000369348.3
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr4_+_159442878 | 4.01 |
ENST00000307765.5
ENST00000423548.1 |
RXFP1
|
relaxin/insulin-like family peptide receptor 1 |
| chr12_-_91576561 | 4.00 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
| chr1_-_72748140 | 3.96 |
ENST00000434200.1
|
NEGR1
|
neuronal growth regulator 1 |
| chr20_-_42815733 | 3.95 |
ENST00000342272.3
|
JPH2
|
junctophilin 2 |
| chr19_+_51152702 | 3.94 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
| chr12_-_91576429 | 3.90 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
| chrX_-_50386648 | 3.88 |
ENST00000460112.3
|
SHROOM4
|
shroom family member 4 |
| chr5_+_175298674 | 3.84 |
ENST00000514150.1
|
CPLX2
|
complexin 2 |
| chr1_-_201342364 | 3.84 |
ENST00000236918.7
ENST00000367317.4 ENST00000367315.2 ENST00000360372.4 |
TNNT2
|
troponin T type 2 (cardiac) |
| chr20_-_656823 | 3.83 |
ENST00000246104.6
|
SCRT2
|
scratch family zinc finger 2 |
| chr11_+_27062860 | 3.82 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr19_+_54412517 | 3.81 |
ENST00000391767.1
|
CACNG7
|
calcium channel, voltage-dependent, gamma subunit 7 |
| chr14_+_79746249 | 3.79 |
ENST00000428277.2
|
NRXN3
|
neurexin 3 |
| chr3_+_29322437 | 3.77 |
ENST00000434693.2
|
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
| chr13_-_78492955 | 3.76 |
ENST00000446573.1
|
EDNRB
|
endothelin receptor type B |
| chr1_-_177133818 | 3.76 |
ENST00000424564.2
ENST00000361833.2 |
ASTN1
|
astrotactin 1 |
| chr1_+_86889769 | 3.74 |
ENST00000370565.4
|
CLCA2
|
chloride channel accessory 2 |
| chr2_-_50574856 | 3.71 |
ENST00000342183.5
|
NRXN1
|
neurexin 1 |
| chr4_+_151503077 | 3.67 |
ENST00000317605.4
|
MAB21L2
|
mab-21-like 2 (C. elegans) |
| chr2_-_198540751 | 3.67 |
ENST00000429081.1
|
RFTN2
|
raftlin family member 2 |
| chr1_-_177134024 | 3.66 |
ENST00000367654.3
|
ASTN1
|
astrotactin 1 |
| chr13_-_53422640 | 3.61 |
ENST00000338862.4
ENST00000377942.3 |
PCDH8
|
protocadherin 8 |
| chr1_+_233749739 | 3.60 |
ENST00000366621.3
|
KCNK1
|
potassium channel, subfamily K, member 1 |
| chr17_+_11501748 | 3.55 |
ENST00000262442.4
ENST00000579828.1 |
DNAH9
|
dynein, axonemal, heavy chain 9 |
| chr22_-_36236623 | 3.55 |
ENST00000405409.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
| chr7_-_137028534 | 3.52 |
ENST00000348225.2
|
PTN
|
pleiotrophin |
| chr12_+_79258444 | 3.49 |
ENST00000261205.4
|
SYT1
|
synaptotagmin I |
| chr5_+_175223313 | 3.49 |
ENST00000359546.4
|
CPLX2
|
complexin 2 |
| chr3_+_29322933 | 3.47 |
ENST00000273139.9
ENST00000383766.2 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
| chr15_-_37390482 | 3.46 |
ENST00000559085.1
ENST00000397624.3 |
MEIS2
|
Meis homeobox 2 |
| chr1_-_153581798 | 3.45 |
ENST00000368704.1
ENST00000368705.2 |
S100A16
|
S100 calcium binding protein A16 |
| chr6_-_56507586 | 3.43 |
ENST00000439203.1
ENST00000518935.1 ENST00000446842.2 ENST00000370765.6 ENST00000244364.6 |
DST
|
dystonin |
| chr14_+_79745682 | 3.43 |
ENST00000557594.1
|
NRXN3
|
neurexin 3 |
| chr19_-_36001286 | 3.42 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
| chr5_-_35938674 | 3.40 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
| chr15_+_43809797 | 3.37 |
ENST00000399453.1
ENST00000300231.5 |
MAP1A
|
microtubule-associated protein 1A |
| chr19_+_35783047 | 3.37 |
ENST00000595791.1
ENST00000597035.1 ENST00000537831.2 |
MAG
|
myelin associated glycoprotein |
| chr6_-_134639235 | 3.35 |
ENST00000533224.1
|
SGK1
|
serum/glucocorticoid regulated kinase 1 |
| chr1_+_47489240 | 3.35 |
ENST00000371901.3
|
CYP4X1
|
cytochrome P450, family 4, subfamily X, polypeptide 1 |
| chr4_+_30721968 | 3.32 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
| chr16_+_29911864 | 3.31 |
ENST00000308748.5
|
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
| chr4_-_168155730 | 3.30 |
ENST00000502330.1
ENST00000357154.3 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr4_-_16900242 | 3.29 |
ENST00000502640.1
ENST00000506732.1 |
LDB2
|
LIM domain binding 2 |
| chrX_-_13835398 | 3.28 |
ENST00000475307.1
|
GPM6B
|
glycoprotein M6B |
| chr10_-_61122220 | 3.28 |
ENST00000422313.2
ENST00000435852.2 ENST00000442566.3 ENST00000373868.2 ENST00000277705.6 ENST00000373867.3 ENST00000419214.2 |
FAM13C
|
family with sequence similarity 13, member C |
| chr5_+_161275320 | 3.27 |
ENST00000437025.2
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
| chr4_-_168155577 | 3.25 |
ENST00000541354.1
ENST00000509854.1 ENST00000512681.1 ENST00000421836.2 ENST00000510741.1 ENST00000510403.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr11_-_111782484 | 3.23 |
ENST00000533971.1
|
CRYAB
|
crystallin, alpha B |
| chr1_-_209824643 | 3.23 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
| chr1_-_116311402 | 3.21 |
ENST00000261448.5
|
CASQ2
|
calsequestrin 2 (cardiac muscle) |
| chr12_-_50294033 | 3.20 |
ENST00000552669.1
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
| chr15_-_45422056 | 3.20 |
ENST00000267803.4
ENST00000559014.1 ENST00000558851.1 ENST00000559988.1 ENST00000558996.1 ENST00000558422.1 ENST00000559226.1 ENST00000558326.1 ENST00000558377.1 ENST00000559644.1 |
DUOXA1
|
dual oxidase maturation factor 1 |
| chr9_+_87286997 | 3.20 |
ENST00000395866.2
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
| chr2_-_55277654 | 3.18 |
ENST00000337526.6
ENST00000317610.7 ENST00000357732.4 |
RTN4
|
reticulon 4 |
| chr2_-_55277692 | 3.17 |
ENST00000394611.2
|
RTN4
|
reticulon 4 |
| chr1_-_163172625 | 3.17 |
ENST00000527988.1
ENST00000531476.1 ENST00000530507.1 |
RGS5
|
regulator of G-protein signaling 5 |
| chr3_-_112360116 | 3.16 |
ENST00000206423.3
ENST00000439685.2 |
CCDC80
|
coiled-coil domain containing 80 |
| chr1_-_153588765 | 3.15 |
ENST00000368701.1
ENST00000344616.2 |
S100A14
|
S100 calcium binding protein A14 |
| chr9_+_133986782 | 3.14 |
ENST00000372301.2
|
AIF1L
|
allograft inflammatory factor 1-like |
| chr11_+_131240373 | 3.11 |
ENST00000374791.3
ENST00000436745.1 |
NTM
|
neurotrimin |
| chr19_-_51141196 | 3.10 |
ENST00000338916.4
|
SYT3
|
synaptotagmin III |
| chr2_+_166326157 | 3.10 |
ENST00000421875.1
ENST00000314499.7 ENST00000409664.1 |
CSRNP3
|
cysteine-serine-rich nuclear protein 3 |
| chr4_-_16900184 | 3.10 |
ENST00000515064.1
|
LDB2
|
LIM domain binding 2 |
| chrX_-_34675391 | 3.09 |
ENST00000275954.3
|
TMEM47
|
transmembrane protein 47 |
| chr17_-_40575535 | 3.08 |
ENST00000357037.5
|
PTRF
|
polymerase I and transcript release factor |
| chr11_-_66496430 | 3.08 |
ENST00000533211.1
|
SPTBN2
|
spectrin, beta, non-erythrocytic 2 |
| chr10_-_98118724 | 3.07 |
ENST00000393870.2
|
OPALIN
|
oligodendrocytic myelin paranodal and inner loop protein |
| chr7_-_117512264 | 3.07 |
ENST00000454375.1
|
CTTNBP2
|
cortactin binding protein 2 |
| chr12_-_91576750 | 3.06 |
ENST00000228329.5
ENST00000303320.3 ENST00000052754.5 |
DCN
|
decorin |
| chr7_-_124405681 | 3.06 |
ENST00000303921.2
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like) |
| chr4_-_16900410 | 3.06 |
ENST00000304523.5
|
LDB2
|
LIM domain binding 2 |
| chr19_-_35625765 | 3.04 |
ENST00000591633.1
|
LGI4
|
leucine-rich repeat LGI family, member 4 |
| chr1_-_190446759 | 3.04 |
ENST00000367462.3
|
BRINP3
|
bone morphogenetic protein/retinoic acid inducible neural-specific 3 |
| chrX_-_151619746 | 3.01 |
ENST00000370314.4
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
| chr5_-_149669192 | 3.01 |
ENST00000398376.3
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha |
| chr4_-_168155169 | 3.00 |
ENST00000534949.1
ENST00000535728.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr11_+_56949221 | 3.00 |
ENST00000497933.1
|
LRRC55
|
leucine rich repeat containing 55 |
| chr14_-_54423529 | 2.99 |
ENST00000245451.4
ENST00000559087.1 |
BMP4
|
bone morphogenetic protein 4 |
| chr4_-_168155700 | 2.99 |
ENST00000357545.4
ENST00000512648.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr20_-_52612705 | 2.99 |
ENST00000434986.2
|
BCAS1
|
breast carcinoma amplified sequence 1 |
| chr9_+_87284622 | 2.98 |
ENST00000395882.1
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
| chr2_-_198540719 | 2.97 |
ENST00000295049.4
|
RFTN2
|
raftlin family member 2 |
| chr1_+_156589051 | 2.97 |
ENST00000255039.1
|
HAPLN2
|
hyaluronan and proteoglycan link protein 2 |
| chr12_+_56477093 | 2.97 |
ENST00000549672.1
ENST00000415288.2 |
ERBB3
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
| chr1_+_181452678 | 2.96 |
ENST00000367570.1
ENST00000526775.1 ENST00000357570.5 ENST00000358338.5 ENST00000367567.4 |
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit |
| chrX_-_13835461 | 2.95 |
ENST00000316715.4
ENST00000356942.5 |
GPM6B
|
glycoprotein M6B |
| chr7_+_121513374 | 2.93 |
ENST00000449182.1
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
| chr7_-_137028498 | 2.93 |
ENST00000393083.2
|
PTN
|
pleiotrophin |
| chr4_+_123747834 | 2.91 |
ENST00000264498.3
|
FGF2
|
fibroblast growth factor 2 (basic) |
| chr7_+_20370746 | 2.90 |
ENST00000222573.4
|
ITGB8
|
integrin, beta 8 |
| chr11_-_40314652 | 2.89 |
ENST00000527150.1
|
LRRC4C
|
leucine rich repeat containing 4C |
| chrX_+_122318006 | 2.89 |
ENST00000371266.1
ENST00000264357.5 |
GRIA3
|
glutamate receptor, ionotropic, AMPA 3 |
| chr7_+_105603683 | 2.89 |
ENST00000317716.9
|
CDHR3
|
cadherin-related family member 3 |
| chr10_-_108924284 | 2.88 |
ENST00000344440.6
ENST00000263054.6 |
SORCS1
|
sortilin-related VPS10 domain containing receptor 1 |
| chr3_+_111717600 | 2.87 |
ENST00000273368.4
|
TAGLN3
|
transgelin 3 |
| chr18_+_29171689 | 2.86 |
ENST00000237014.3
|
TTR
|
transthyretin |
| chr12_-_75603643 | 2.85 |
ENST00000549446.1
|
KCNC2
|
potassium voltage-gated channel, Shaw-related subfamily, member 2 |
| chr17_+_36584662 | 2.85 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
| chr12_-_71533055 | 2.84 |
ENST00000552128.1
|
TSPAN8
|
tetraspanin 8 |
| chr17_-_7123021 | 2.84 |
ENST00000399510.2
|
DLG4
|
discs, large homolog 4 (Drosophila) |
| chr11_-_123065989 | 2.83 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
| chr6_-_131277510 | 2.82 |
ENST00000525193.1
ENST00000527659.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
| chr5_+_140749803 | 2.82 |
ENST00000576222.1
|
PCDHGB3
|
protocadherin gamma subfamily B, 3 |
| chr6_+_146350267 | 2.81 |
ENST00000355289.4
ENST00000282753.1 |
GRM1
|
glutamate receptor, metabotropic 1 |
| chr2_+_210517895 | 2.80 |
ENST00000447185.1
|
MAP2
|
microtubule-associated protein 2 |
| chr2_-_241737128 | 2.80 |
ENST00000404283.3
|
KIF1A
|
kinesin family member 1A |
| chr8_-_18666360 | 2.80 |
ENST00000286485.8
|
PSD3
|
pleckstrin and Sec7 domain containing 3 |
| chr6_+_29624898 | 2.80 |
ENST00000396704.3
ENST00000483013.1 ENST00000490427.1 ENST00000416766.2 ENST00000376891.4 ENST00000376898.3 ENST00000396701.2 ENST00000494692.1 ENST00000431798.2 |
MOG
|
myelin oligodendrocyte glycoprotein |
| chr19_-_4338783 | 2.76 |
ENST00000601482.1
ENST00000600324.1 |
STAP2
|
signal transducing adaptor family member 2 |
| chr8_+_80523962 | 2.75 |
ENST00000518491.1
|
STMN2
|
stathmin-like 2 |
| chr15_-_74043816 | 2.74 |
ENST00000379822.4
|
C15orf59
|
chromosome 15 open reading frame 59 |
| chrX_+_103031758 | 2.73 |
ENST00000303958.2
ENST00000361621.2 |
PLP1
|
proteolipid protein 1 |
| chr7_-_31380502 | 2.71 |
ENST00000297142.3
|
NEUROD6
|
neuronal differentiation 6 |
| chr6_+_153071925 | 2.69 |
ENST00000367244.3
ENST00000367243.3 |
VIP
|
vasoactive intestinal peptide |
| chr5_+_140571902 | 2.69 |
ENST00000239446.4
|
PCDHB10
|
protocadherin beta 10 |
| chr4_-_168155300 | 2.68 |
ENST00000541637.1
|
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr12_-_75603482 | 2.68 |
ENST00000341669.3
ENST00000298972.1 ENST00000350228.2 |
KCNC2
|
potassium voltage-gated channel, Shaw-related subfamily, member 2 |
| chr12_+_121088291 | 2.68 |
ENST00000351200.2
|
CABP1
|
calcium binding protein 1 |
| chr19_-_35992780 | 2.67 |
ENST00000593342.1
ENST00000601650.1 ENST00000408915.2 |
DMKN
|
dermokine |
| chr3_-_99569821 | 2.63 |
ENST00000487087.1
|
FILIP1L
|
filamin A interacting protein 1-like |
| chr12_-_115121962 | 2.62 |
ENST00000349155.2
|
TBX3
|
T-box 3 |
| chr7_-_38671098 | 2.61 |
ENST00000356264.2
|
AMPH
|
amphiphysin |
| chr6_+_46620705 | 2.61 |
ENST00000452689.2
|
SLC25A27
|
solute carrier family 25, member 27 |
| chr12_-_6484715 | 2.60 |
ENST00000228916.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr4_-_168155417 | 2.60 |
ENST00000511269.1
ENST00000506697.1 ENST00000512042.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr20_+_17207665 | 2.60 |
ENST00000536609.1
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2 |
| chr15_+_43986069 | 2.59 |
ENST00000415044.1
|
CKMT1A
|
creatine kinase, mitochondrial 1A |
| chr7_-_120498357 | 2.59 |
ENST00000415871.1
ENST00000222747.3 ENST00000430985.1 |
TSPAN12
|
tetraspanin 12 |
| chr3_-_116163830 | 2.58 |
ENST00000333617.4
|
LSAMP
|
limbic system-associated membrane protein |
| chr1_+_95286151 | 2.57 |
ENST00000467909.1
ENST00000422520.2 ENST00000532427.1 |
SLC44A3
|
solute carrier family 44, member 3 |
| chr16_+_7382745 | 2.56 |
ENST00000436368.2
ENST00000311745.5 ENST00000355637.4 ENST00000340209.4 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr1_-_153588334 | 2.56 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
| chr6_+_17393839 | 2.55 |
ENST00000489374.1
ENST00000378990.2 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr3_+_178276488 | 2.54 |
ENST00000432997.1
ENST00000455865.1 |
KCNMB2
|
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
| chrX_-_138724677 | 2.53 |
ENST00000370573.4
ENST00000338585.6 ENST00000370576.4 |
MCF2
|
MCF.2 cell line derived transforming sequence |
| chr17_+_68100989 | 2.51 |
ENST00000585558.1
ENST00000392670.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
| chr13_+_113633620 | 2.51 |
ENST00000421756.1
ENST00000375601.3 |
MCF2L
|
MCF.2 cell line derived transforming sequence-like |
| chr1_+_156589198 | 2.51 |
ENST00000456112.1
|
HAPLN2
|
hyaluronan and proteoglycan link protein 2 |
| chr6_-_47010061 | 2.51 |
ENST00000371253.2
|
GPR110
|
G protein-coupled receptor 110 |
| chr3_+_164924716 | 2.50 |
ENST00000470138.1
ENST00000498616.1 |
RP11-85M11.2
|
RP11-85M11.2 |
| chr1_+_50574585 | 2.49 |
ENST00000371824.1
ENST00000371823.4 |
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
| chr6_+_12749657 | 2.49 |
ENST00000406205.2
|
PHACTR1
|
phosphatase and actin regulator 1 |
| chr13_-_78492927 | 2.49 |
ENST00000334286.5
|
EDNRB
|
endothelin receptor type B |
Network of associatons between targets according to the STRING database.
First level regulatory network of EZH2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 6.5 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
| 2.1 | 6.2 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
| 1.7 | 6.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 1.6 | 22.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 1.4 | 4.3 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 1.2 | 15.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 1.2 | 8.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 1.1 | 9.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 1.1 | 9.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 1.0 | 6.2 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 1.0 | 25.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 1.0 | 2.9 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 1.0 | 5.8 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 1.0 | 23.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 1.0 | 3.8 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.9 | 4.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.9 | 15.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.9 | 15.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.9 | 5.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.9 | 9.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.9 | 2.6 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
| 0.9 | 2.6 | GO:0060596 | mammary placode formation(GO:0060596) sinoatrial node cell development(GO:0060931) |
| 0.8 | 23.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.8 | 11.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.8 | 2.4 | GO:0086044 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.7 | 2.2 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.7 | 1.5 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.7 | 4.4 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.7 | 0.7 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.7 | 2.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.7 | 2.1 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.7 | 2.8 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.7 | 9.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.7 | 5.5 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.7 | 2.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.7 | 9.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.7 | 4.0 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.7 | 2.6 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.7 | 3.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.6 | 3.8 | GO:0048389 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
| 0.6 | 15.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.6 | 6.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.6 | 10.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.6 | 6.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.6 | 6.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.6 | 0.6 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
| 0.6 | 1.8 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.6 | 4.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.6 | 3.5 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.6 | 6.2 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.6 | 9.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.6 | 7.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.6 | 8.4 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.6 | 22.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.5 | 10.9 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.5 | 4.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.5 | 4.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.5 | 2.1 | GO:0048686 | modulation by virus of host transcription(GO:0019056) regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.5 | 0.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.5 | 0.5 | GO:0071918 | urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.5 | 2.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.5 | 2.6 | GO:0030070 | insulin processing(GO:0030070) |
| 0.5 | 8.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.5 | 3.1 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.5 | 1.5 | GO:0061055 | myotome development(GO:0061055) |
| 0.5 | 4.2 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.5 | 3.7 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 0.5 | 2.3 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.5 | 1.8 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.4 | 4.9 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.4 | 1.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.4 | 4.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.4 | 4.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.4 | 0.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 0.4 | 12.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.4 | 7.3 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.4 | 3.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.4 | 3.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.4 | 1.6 | GO:0060067 | chemoattraction of serotonergic neuron axon(GO:0036517) cervix development(GO:0060067) lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
| 0.4 | 0.8 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.4 | 1.2 | GO:0060437 | lung growth(GO:0060437) |
| 0.4 | 1.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.4 | 1.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.4 | 21.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.4 | 1.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.4 | 4.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.4 | 1.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
| 0.4 | 1.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 | 1.8 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.4 | 7.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.3 | 1.4 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.3 | 2.8 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.3 | 1.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.3 | 2.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.3 | 2.7 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.3 | 2.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 | 4.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.3 | 1.6 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.3 | 0.9 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.3 | 2.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 | 2.1 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.3 | 4.0 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.3 | 3.0 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 | 1.8 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.3 | 3.6 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
| 0.3 | 2.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.3 | 0.9 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 | 0.3 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.3 | 4.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.3 | 2.6 | GO:0003383 | apical constriction(GO:0003383) |
| 0.3 | 2.3 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.3 | 5.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.3 | 2.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.3 | 6.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.3 | 3.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.3 | 1.4 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.3 | 1.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.3 | 1.1 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.3 | 10.8 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.3 | 2.2 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
| 0.3 | 5.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.3 | 0.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.3 | 10.0 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.3 | 1.8 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.3 | 1.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.3 | 1.0 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.3 | 2.5 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.3 | 13.6 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.2 | 0.7 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.2 | 3.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.2 | 8.8 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.2 | 1.9 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.2 | 0.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 | 2.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.2 | 1.2 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 0.2 | 2.4 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
| 0.2 | 1.1 | GO:1903276 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.2 | 2.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 1.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.2 | 1.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.2 | 1.8 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
| 0.2 | 1.8 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.2 | 0.2 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.2 | 10.1 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.2 | 1.8 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.2 | 0.4 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.2 | 0.6 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.2 | 0.4 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.2 | 2.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 | 0.6 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
| 0.2 | 5.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.2 | 2.4 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 | 3.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.2 | 4.8 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.2 | 1.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.2 | 42.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 | 3.4 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.2 | 0.9 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.2 | 1.9 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.2 | 1.1 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.2 | 0.7 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.2 | 1.5 | GO:0032439 | endosome localization(GO:0032439) |
| 0.2 | 1.3 | GO:0022605 | ovarian cumulus expansion(GO:0001550) oogenesis stage(GO:0022605) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.2 | 0.9 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.2 | 2.0 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.2 | 1.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.2 | 2.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.2 | 2.6 | GO:0015871 | choline transport(GO:0015871) |
| 0.2 | 2.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.2 | 0.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.2 | 10.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.2 | 0.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 | 0.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.2 | 1.1 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.2 | 1.1 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.2 | 0.5 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.2 | 0.9 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.2 | 3.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.2 | 4.3 | GO:0006833 | water transport(GO:0006833) |
| 0.2 | 7.4 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.2 | 0.8 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.2 | 1.4 | GO:1901731 | calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.2 | 1.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.2 | 1.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.1 | 5.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 1.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 1.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 | 3.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 2.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.1 | 3.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 | 5.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.1 | 1.0 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 1.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.1 | 3.0 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
| 0.1 | 0.7 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.1 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 0.9 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 | 2.6 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 | 1.6 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
| 0.1 | 0.8 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.1 | 0.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.1 | 1.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 | 1.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 | 0.7 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 6.7 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.1 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.1 | 0.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 | 1.7 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 | 2.0 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.1 | 0.5 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 0.1 | 1.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 0.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.1 | 2.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.1 | 1.4 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
| 0.1 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.1 | 0.3 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
| 0.1 | 0.7 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.1 | 1.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.1 | 2.2 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 3.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 2.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 | 1.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.1 | 0.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 | 1.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 1.6 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 0.5 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
| 0.1 | 0.9 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.1 | 2.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 1.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 | 0.3 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.1 | 0.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 | 11.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 1.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 1.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 4.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.1 | 0.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.1 | 2.4 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.1 | 0.5 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.1 | 1.4 | GO:0061387 | regulation of extent of cell growth(GO:0061387) |
| 0.1 | 0.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 0.1 | 3.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 2.4 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.1 | 2.3 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 | 3.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.1 | 0.3 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 | 1.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.9 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 2.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 0.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 | 0.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 | 0.3 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 1.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 | 0.2 | GO:0090259 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) regulation of retinal ganglion cell axon guidance(GO:0090259) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.1 | 2.7 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 0.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 1.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 1.9 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.1 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 | 1.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 4.8 | GO:0008542 | visual learning(GO:0008542) |
| 0.1 | 1.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.1 | 1.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 1.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 1.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.1 | 4.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 | 0.9 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 | 0.5 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.1 | 1.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 1.0 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.1 | 2.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.1 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.1 | 1.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.1 | 0.3 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 | 2.9 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.1 | 1.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 | 0.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 | 0.4 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.1 | 6.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
| 0.1 | 2.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 1.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 1.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 0.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.1 | 1.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.6 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 | 1.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 0.3 | GO:0097090 | presynaptic membrane organization(GO:0097090) postsynaptic membrane assembly(GO:0097104) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 | 3.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.1 | 0.3 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.1 | 2.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 1.7 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.1 | 1.3 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.1 | 0.9 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 2.8 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.1 | 0.8 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.1 | 1.0 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.3 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.1 | 0.8 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.1 | 4.2 | GO:0003341 | cilium movement(GO:0003341) |
| 0.1 | 1.9 | GO:0031638 | zymogen activation(GO:0031638) |
| 0.1 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 1.8 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.1 | 0.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 | 1.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 | 1.3 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.1 | 0.4 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.1 | 1.6 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.1 | 0.4 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.1 | 3.9 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.1 | 1.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 | 1.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 0.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.1 | 1.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 2.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.1 | 7.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
| 0.1 | 1.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 | 1.0 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.0 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.0 | 0.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.0 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 2.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.4 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.0 | 1.4 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.0 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.0 | 1.8 | GO:0042551 | neuron maturation(GO:0042551) |
| 0.0 | 0.5 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.0 | 1.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.0 | 2.2 | GO:0007588 | excretion(GO:0007588) |
| 0.0 | 0.0 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
| 0.0 | 0.4 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 | 1.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.0 | 2.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 1.8 | GO:0098930 | anterograde axonal transport(GO:0008089) axonal transport(GO:0098930) |
| 0.0 | 0.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.9 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.0 | 1.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 | 3.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 | 0.8 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
| 0.0 | 3.4 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 | 2.3 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.0 | 0.4 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.0 | 0.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 | 0.3 | GO:0050803 | regulation of synapse structure or activity(GO:0050803) |
| 0.0 | 1.2 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.0 | 4.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 4.5 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
| 0.0 | 7.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
| 0.0 | 2.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 0.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.0 | 2.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 | 0.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.0 | 0.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.0 | 1.6 | GO:0072659 | protein localization to plasma membrane(GO:0072659) |
| 0.0 | 0.0 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 | 0.6 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 1.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 | 0.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 2.5 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.1 | GO:0044314 | protein K29-linked ubiquitination(GO:0035519) protein K27-linked ubiquitination(GO:0044314) |
| 0.0 | 2.3 | GO:0042552 | myelination(GO:0042552) |
| 0.0 | 0.1 | GO:0010224 | response to UV-B(GO:0010224) |
| 0.0 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.0 | 0.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.0 | 3.4 | GO:0007605 | sensory perception of sound(GO:0007605) |
| 0.0 | 1.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 2.8 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 3.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 | 0.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 0.8 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 | 0.9 | GO:0019233 | sensory perception of pain(GO:0019233) |
| 0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.0 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 | 0.4 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.0 | 1.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.0 | 0.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 0.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.6 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
| 0.0 | 1.0 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.0 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.0 | 0.3 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 | 0.9 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 | 0.2 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 | 0.2 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.0 | 0.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.0 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.0 | 0.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 | 1.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.0 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 | 0.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 | 0.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.0 | 0.4 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
| 0.0 | 0.1 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.2 | GO:0017145 | stem cell division(GO:0017145) |
| 0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.0 | 0.0 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 0.0 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.0 | 0.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 0.1 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.0 | 0.1 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
| 0.0 | 0.4 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 22.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 1.8 | 20.2 | GO:0032584 | growth cone membrane(GO:0032584) |
| 1.8 | 5.5 | GO:0097447 | dendritic tree(GO:0097447) |
| 1.7 | 5.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 1.6 | 29.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 1.1 | 3.4 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 1.1 | 14.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.0 | 4.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.9 | 9.6 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.8 | 3.4 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.7 | 2.9 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.7 | 11.0 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.7 | 3.6 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.7 | 5.0 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.6 | 5.8 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.6 | 4.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.6 | 1.8 | GO:0043257 | laminin-8 complex(GO:0043257) |
| 0.6 | 3.4 | GO:0031673 | H zone(GO:0031673) |
| 0.5 | 11.1 | GO:0008091 | spectrin(GO:0008091) |
| 0.5 | 27.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.5 | 1.9 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.5 | 3.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.5 | 1.4 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.5 | 8.2 | GO:0045179 | apical cortex(GO:0045179) |
| 0.5 | 15.8 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.4 | 1.3 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.4 | 3.9 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.4 | 6.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.4 | 1.9 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.4 | 1.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.4 | 10.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 10.5 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.3 | 2.7 | GO:1990393 | 3M complex(GO:1990393) |
| 0.3 | 1.0 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.3 | 5.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.3 | 4.8 | GO:0060091 | kinocilium(GO:0060091) |
| 0.3 | 1.8 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.3 | 3.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.3 | 7.6 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.3 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
| 0.3 | 0.8 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.3 | 9.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 2.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.2 | 1.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.2 | 2.3 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.2 | 4.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.2 | 8.3 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.2 | 1.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.2 | 2.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.2 | 4.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.2 | 0.8 | GO:0031592 | centrosomal corona(GO:0031592) |
| 0.2 | 0.6 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.2 | 1.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.2 | 1.6 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.2 | 27.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.2 | 2.0 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.2 | 6.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 1.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.2 | 26.7 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.2 | 1.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.2 | 1.7 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.2 | 2.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.2 | 0.5 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.2 | 7.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.2 | 2.0 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.2 | 2.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.1 | 7.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 2.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.1 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 1.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 1.6 | GO:0044297 | cell body(GO:0044297) |
| 0.1 | 4.1 | GO:0032982 | myosin filament(GO:0032982) |
| 0.1 | 4.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.1 | 1.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.1 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 31.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.1 | 1.9 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 18.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.1 | 25.1 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.1 | 1.8 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 2.2 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 1.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 2.0 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 0.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 1.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.1 | 17.0 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 22.2 | GO:0030426 | growth cone(GO:0030426) |
| 0.1 | 0.9 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.1 | 2.3 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.1 | 0.3 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.1 | 2.9 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 1.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 0.9 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.1 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 2.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 25.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.1 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 1.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 40.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.1 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 0.6 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 1.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 4.6 | GO:0030286 | dynein complex(GO:0030286) |
| 0.1 | 0.8 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 1.9 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.1 | 1.5 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 1.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 1.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 3.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 0.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.1 | 1.7 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 4.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 3.8 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 1.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 15.7 | GO:0030424 | axon(GO:0030424) |
| 0.1 | 0.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.1 | 1.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 19.6 | GO:0098793 | presynapse(GO:0098793) |
| 0.1 | 2.1 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.1 | 5.9 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 15.3 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.1 | 1.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 0.1 | 5.6 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 9.3 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.0 | 1.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.0 | 0.6 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.9 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 1.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.0 | 6.8 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.0 | 1.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 1.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.0 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.0 | 1.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.7 | GO:0005861 | troponin complex(GO:0005861) |
| 0.0 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.0 | 2.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 2.8 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 2.0 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.0 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 4.5 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.0 | 3.1 | GO:0005911 | cell-cell junction(GO:0005911) |
| 0.0 | 0.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.0 | 0.5 | GO:0090543 | Flemming body(GO:0090543) |
| 0.0 | 5.0 | GO:0030016 | myofibril(GO:0030016) |
| 0.0 | 1.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 5.1 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 1.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 0.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.0 | 1.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.0 | 1.1 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.0 | 1.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 0.7 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 3.1 | GO:0043235 | receptor complex(GO:0043235) |
| 0.0 | 2.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 15.9 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 2.4 | 7.3 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 2.1 | 6.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 1.9 | 11.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 1.7 | 18.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 1.6 | 6.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 1.6 | 15.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.4 | 4.2 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 1.4 | 4.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.2 | 23.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 1.2 | 19.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 1.1 | 9.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 1.0 | 6.2 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 1.0 | 8.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.9 | 2.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.9 | 8.4 | GO:0042835 | BRE binding(GO:0042835) |
| 0.9 | 11.7 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.8 | 5.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.8 | 2.4 | GO:0086078 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
| 0.8 | 24.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.8 | 2.3 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 0.7 | 3.0 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
| 0.7 | 3.0 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.7 | 4.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.7 | 6.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.7 | 3.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.6 | 5.8 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.6 | 11.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.5 | 3.3 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.5 | 5.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.5 | 1.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.5 | 4.2 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.5 | 4.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.5 | 2.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.5 | 2.0 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.5 | 3.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.5 | 2.8 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.5 | 9.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.4 | 4.0 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.4 | 1.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.4 | 2.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.4 | 2.1 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.4 | 8.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.4 | 4.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.4 | 1.6 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.4 | 3.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.4 | 12.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.4 | 3.1 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.4 | 3.9 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.4 | 9.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.4 | 12.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.4 | 1.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.4 | 1.5 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.4 | 1.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.4 | 1.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.4 | 16.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.4 | 1.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.4 | 2.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.3 | 1.7 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.3 | 1.0 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.3 | 3.8 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.3 | 4.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.3 | 5.4 | GO:0015250 | water channel activity(GO:0015250) |
| 0.3 | 1.0 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.3 | 9.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.3 | 0.6 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.3 | 1.9 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.3 | 1.8 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.3 | 1.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.3 | 1.7 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.3 | 2.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.3 | 9.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.3 | 1.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.3 | 2.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.3 | 2.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.3 | 2.8 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.3 | 0.8 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.2 | 5.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 1.7 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.2 | 7.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.2 | 3.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.2 | 1.2 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.2 | 7.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.2 | 0.7 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.2 | 13.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.2 | 1.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.2 | 1.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.2 | 3.0 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.2 | 0.7 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
| 0.2 | 1.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.2 | 1.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.2 | 1.1 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.2 | 2.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.2 | 0.9 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.2 | 2.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.2 | 5.8 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.2 | 5.6 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.2 | 2.8 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.2 | 1.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.2 | 3.4 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 0.6 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.2 | 2.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.2 | 1.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.2 | 1.6 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.2 | 16.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.2 | 1.3 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.2 | 5.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.2 | 6.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.2 | 2.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.2 | 6.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 6.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.2 | 2.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.2 | 1.2 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.2 | 15.0 | GO:0022839 | ion gated channel activity(GO:0022839) |
| 0.2 | 0.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.2 | 2.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 1.1 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.2 | 3.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.2 | 0.5 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.2 | 2.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.1 | 3.4 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.1 | 3.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 0.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.1 | 10.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 17.0 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 1.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.1 | 3.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 20.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.1 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.1 | 2.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 11.6 | GO:0005267 | potassium channel activity(GO:0005267) |
| 0.1 | 1.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 2.5 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.1 | 1.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.1 | 2.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 3.1 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.1 | 2.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 2.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 0.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 10.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 9.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 3.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 2.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 1.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 0.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.1 | 1.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.1 | 0.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.1 | 1.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 6.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 3.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 1.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.1 | 0.9 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 2.7 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.1 | 4.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 3.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 3.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 1.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.1 | 0.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.1 | 1.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 1.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 0.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 1.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 7.3 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.1 | 0.3 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
| 0.1 | 1.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.1 | 2.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 1.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.1 | 0.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 0.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 2.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 0.7 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 1.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 1.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 1.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.1 | 0.9 | GO:0009374 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
| 0.1 | 7.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.1 | 0.4 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.1 | 22.8 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.9 | GO:0031432 | titin binding(GO:0031432) |
| 0.1 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.1 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 1.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 0.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 0.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.1 | 0.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 6.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 0.6 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 2.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 2.6 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.1 | 1.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.1 | 2.3 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.1 | 1.8 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.1 | 0.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 1.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 1.4 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 3.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 4.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.0 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 48.4 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 0.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
| 0.0 | 1.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.0 | 2.2 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 1.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 2.2 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.0 | 3.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 1.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 0.5 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.0 | 0.7 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.0 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.0 | 7.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 1.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.0 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.0 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 0.5 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
| 0.0 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 4.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 1.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 1.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
| 0.0 | 0.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.0 | 1.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 6.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.0 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 1.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.0 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.0 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 1.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.0 | 1.6 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.0 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.0 | 0.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 1.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.0 | 1.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 0.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.0 | 4.8 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.0 | 0.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 0.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.0 | 1.8 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
| 0.0 | 0.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.0 | 0.9 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.0 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 1.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 0.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 27.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.3 | 24.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.2 | 14.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.2 | 8.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 6.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.2 | 7.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 5.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.2 | 0.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.2 | 11.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 3.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 5.5 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 12.7 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 12.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 14.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.1 | 2.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 5.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 2.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.1 | 4.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 5.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 4.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 1.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.1 | 8.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 3.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 2.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 1.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 1.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 6.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 1.8 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 2.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 3.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 7.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 5.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 14.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 1.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.9 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 10.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 3.4 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 8.1 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
| 0.0 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 0.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 1.1 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 1.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.7 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 0.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 0.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 10.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.6 | 27.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.5 | 9.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.4 | 5.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.3 | 17.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.3 | 8.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.3 | 16.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.3 | 1.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.3 | 7.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.3 | 2.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.3 | 2.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.3 | 4.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.2 | 9.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.2 | 6.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.2 | 5.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.2 | 10.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 6.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 11.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.2 | 11.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 4.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.2 | 10.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 3.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 10.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.2 | 55.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 9.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 7.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 2.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.1 | 9.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 4.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 2.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 2.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 2.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 16.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 4.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 6.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 2.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 2.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 3.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 2.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 2.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.1 | 2.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 3.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 19.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 4.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.1 | 6.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 1.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 1.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.1 | 1.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 2.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 1.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 0.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 1.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.0 | 8.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 1.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.0 | 1.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.0 | 1.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.0 | 2.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.0 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.0 | 0.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.0 | 2.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 1.5 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 0.0 | 0.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.0 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.0 | 2.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.0 | 2.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.0 | 2.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.0 | 0.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.0 | 1.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.9 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.0 | 0.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.0 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.0 | 2.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 1.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 1.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 0.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |